Namodenoson
CF102-301HCC
Phase 3 small_molecule active
Quick answer
Namodenoson for Hepatocellular Carcinoma is a Phase 3 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active